https://www.avient.com/news/robert-m-patterson-becomes-ceo-polyone-corporation-shareholders-approve-all-proposals-2014-annual-meeting
We have a proven strategy, a superb team, and a track record of executing with excellence.
https://www.avient.com/content/first-quarter-2025-results
Earnings webcast recording, slide presentation, and press release available at https://www.avient.com/investors/events-presentations.
https://www.avient.com/sites/default/files/2022-05/ColorMatrix Amosorb Solo Technical Bulletin.pdf
The table and graph below
summarize the values of the plaques recorded
for L*, a*, and b*, throughout the different 5-melt
histories.
It appears from both the picture of the plaques as well as the L*, a*, and b* values recorded, that the presence
of 4% Amosorb SolO2-2 in combination with Avient Fortis Amber-1 at 0.09%, does not cause a significant
change in the appearance of the plaques.
The L*, a*, and b* values recorded in the table below
are also well in accordance with what can be visualized
in Figure 2, where there is a shift in the b* value
indicating a decrease in yellow tone.
https://www.avient.com/sites/default/files/2022-04/Avient Announces Agreement to Acquire Dyneema_0.pdf
A recording of the webcast and the slide presentation will be available at
avient.com/investors.
In addition, a recording of the audio will be available for one week,
beginning at noon EST on Wednesday, April 20, 2022.
To listen to this recording, dial 1-855-859-
2056 (domestic) or 1-404-537-3406 (international) and provide conference ID number 4774915.
https://www.avient.com/investor-center/news/polyone-announces-fourth-quarter-and-full-year-2016-results
Record operating income in Specialty Engineered Materials, Performance Products & Solutions and Distribution
A recording of the call will also be available for one week, beginning at
To listen to this recording, dial 1-855-859-2056 (domestic) or 1-404-537-3406 (international) and enter conference ID number 86775774.
https://www.avient.com/investor-center/news/polyone-announces-second-quarter-2018-results
Our Color, Additives & Inks segment led the way with record operating income, driven by both organic gains and the acquisitions of
We have a track record of generating strong free cash flow, and this was once again the case in the second quarter," said
A recording of the call will also be available for one week, beginning at
https://www.avient.com/sites/default/files/2021-04/avnt-fourth-quarter-2020-news-release.pdf
I am extremely pleased with our record fourth quarter results, as every segment and end
market grew over the prior year fourth quarter.
A recording of the webcast and the investor presentation will be available at avient.com/
investors.
In addition, a recording of the audio will be available for one week, beginning at 12:00
p.m.
https://www.avient.com/sites/default/files/2022-02/Q4 2021 Avient Earnings Release_0.pdf
The company reported sales growth of 27% for the full year compared to 2020, with all segments
delivering record sales and operating income.
A recording of the webcast and the slide presentation will be available at avient.com/investors.
In addition, a recording of the audio will be available for one week, beginning at 11:00 a.m.
https://www.avient.com/sites/default/files/2021-04/avnt-first-quarter-2021-news-release.pdf
The company noted the following segment highlights:
The Color, Additives and Inks segment delivered record operating income of $89 million during
the first quarter, a 40% increase over the prior year.
A recording of the webcast and the slide presentation will be available at avient.com/investors.
In addition, a recording of the audio will be available for one week, beginning at 12:00 p.m.
https://www.avient.com/sites/default/files/resources/Terms_and_Conditions_of_Sale_for_Finland_%2528English_Language_Version%2529.pdf
If Buyer fails
to disseminate such warnings and information, Buyer will indemnify, defend
and save Seller harmless against any and all liability arising out of or in any way
connected with such failure, including without limitation, liability for injury,
sickness, death and property damage.
12.